daclatasvir
General
Genetic Implications:
**Off Market Drug**
This medication is no longer available in the United States. Information provided here is for reference purposes only.
Pronunciation:
da-kla-tass-veer
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Daklinza
Ther. Class.
Pharm. Class.
NS5A inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Daclatasvir." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110355/all/daclatasvir.
Vallerand AHA, Sanoski CAC. Daclatasvir. Davis's Drug Guide. F.A. Davis Company; 2026. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110355/all/daclatasvir. Accessed June 25, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Daclatasvir. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110355/all/daclatasvir
Vallerand AHA, Sanoski CAC. Daclatasvir [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 June 25]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110355/all/daclatasvir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - daclatasvir
ID - 110355
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110355/all/daclatasvir
PB - F.A. Davis Company
ET - 20
DB - Medicine Central
DP - Unbound Medicine
ER -

Davis's Drug Guide

